Secnidazole
| |
Clinical data | |
---|---|
Trade names | Solosec |
Synonyms | PM 185184, RP 14539 |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
ECHA InfoCard |
100.020.123 |
Chemical and physical data | |
Formula | C7H11N3O3 |
Molar mass | 185.180 g/mol |
3D model (JSmol) | |
| |
| |
|
Secnidazole (trade names Flagentyl, Sindose, Secnil, Solosec) is a nitroimidazole anti-infective. Effectiveness in the treatment of dientamoebiasis has been reported.[1] It has also been tested against Atopobium vaginae.[2]
On the United States, secnidazole is approved for the treatment of bacterial vaginosis in adult women.[3]
References
- ↑ Girginkardeşler, N.; Coşkun, S.; Cüneyt Balcioğlu, I.; Ertan, P.; Ok, U. Z. (2003). "Dientamoeba fragilis, a neglected cause of diarrhea, successfully treated with secnidazole". Clinical Microbiology and Infection. 9 (2): 110–113. doi:10.1046/j.1469-0691.2003.00504.x. PMID 12588330.
- ↑ De Backer, E.; Dubreuil, L.; Brauman, M.; Acar, J.; Vaneechoutte, M. (2009). "In vitro activity of secnidazole against Atopobium vaginae, an anaerobic pathogen involved in bacterial vaginosis". Clinical Microbiology and Infection. 16 (5): 470–472. doi:10.1111/j.1469-0691.2009.02852.x. PMID 19548924.
- ↑ "FDA Approves Symbiomix Therapeutics' Solosec (secnidazole) Oral Granules for the Treatment of Bacterial Vaginosis in Adult Women" (Press release). Symbiomix Therapeutics.
External links
- Gillis, J. C.; Wiseman, L. R. (1996). "Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis". Drugs. 51 (4): 621–38. doi:10.2165/00003495-199651040-00007. PMID 8706597.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.